BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 20652767)

  • 1. Treating hyperglycemia in neurocritical patients: benefits and perils.
    Godoy DA; Di Napoli M; Rabinstein AA
    Neurocrit Care; 2010 Dec; 13(3):425-38. PubMed ID: 20652767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive insulin therapy in the neurocritical care setting is associated with poor clinical outcomes.
    Graffagnino C; Gurram AR; Kolls B; Olson DM
    Neurocrit Care; 2010 Dec; 13(3):307-12. PubMed ID: 21086066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive versus conventional insulin therapy in critically ill neurologic patients.
    Green DM; O'Phelan KH; Bassin SL; Chang CW; Stern TS; Asai SM
    Neurocrit Care; 2010 Dec; 13(3):299-306. PubMed ID: 20697836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of time on intensive insulin therapy predicts severe hypoglycemia in the surgically critically ill population.
    Mowery NT; Gunter OL; Kauffmann RM; Diaz JJ; Collier BC; May AK
    World J Surg; 2012 Feb; 36(2):270-7. PubMed ID: 22113844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis.
    Kramer AH; Roberts DJ; Zygun DA
    Crit Care; 2012 Oct; 16(5):R203. PubMed ID: 23082798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose control in the intensive care unit.
    Fahy BG; Sheehy AM; Coursin DB
    Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The optimal blood glucose target in critically ill patient: comparison of two intensive insulin therapy protocols].
    Raurell Torredà M; del Llano Serrano C; Almirall Solsona D; Catalan Ibars RM; Nicolás Arfelis JM
    Med Clin (Barc); 2014 Mar; 142(5):192-9. PubMed ID: 23490488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of perioperative glucose control in the neurosurgical population.
    Atkins JH; Smith DS
    J Diabetes Sci Technol; 2009 Nov; 3(6):1352-64. PubMed ID: 20144389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intensive insulin therapy on insulin sensitivity in the critically ill.
    Langouche L; Vander Perre S; Wouters PJ; D'Hoore A; Hansen TK; Van den Berghe G
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3890-7. PubMed ID: 17666481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic control in the critically ill patient an update: hyperglycemia, glucose variability hypoglycemia and relative hypoglycemia].
    Pérez-Calatayud ÁA; Guillén-Vidaña A; Fraire-Félix IS; Anica-Malagón ED; Briones Garduño JC; Carrillo-Esper R
    Cir Cir; 2017; 85(1):93-100. PubMed ID: 27998542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive insulin therapy in the intensive care unit, hypoglycemia, and cardiovascular mortality.
    Rana O; Byrne CD; Greaves K
    Hosp Pract (1995); 2010 Apr; 38(2):59-66. PubMed ID: 20469614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin Therapy in Hospitalized Patients.
    Pérez A; Ramos A; Carreras G
    Am J Ther; 2020; 27(1):e71-e78. PubMed ID: 31833876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paediatric endocrinology: Tight glycaemic control in critically ill children.
    Van den Berghe G; Mesotten D
    Nat Rev Endocrinol; 2014 Apr; 10(4):196-7. PubMed ID: 24535207
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hyperglycemia in the critically ill: meaning and treatment].
    Schlienger JL; Pradignac A; Vinzio S; Luca F; Suna C; Grunenberger F; Goichot B
    Presse Med; 2009 Apr; 38(4):562-70. PubMed ID: 19056206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive insulin therapy in hospitalized patients: a systematic review.
    Kansagara D; Fu R; Freeman M; Wolf F; Helfand M
    Ann Intern Med; 2011 Feb; 154(4):268-82. PubMed ID: 21320942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tight glucose control in critically ill children--a systematic review and meta-analysis.
    Srinivasan V; Agus MS
    Pediatr Diabetes; 2014 Mar; 15(2):75-83. PubMed ID: 24783254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intensive insulin therapy on the somatotropic axis of critically ill children.
    Gielen M; Mesotten D; Brugts M; Coopmans W; Van Herck E; Vanhorebeek I; Baxter R; Lamberts S; Janssen JA; Van den Berghe G
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2558-66. PubMed ID: 21632816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive insulin therapy increases the risk of hypoglycemia in neurocritical care patients.
    Tiemessen CA; Hoedemaekers CW; van Iersel FM; Rösken GH; van der Hoeven J; Biessels GJ; Slooter AJ
    J Neurosurg Anesthesiol; 2011 Jul; 23(3):206-14. PubMed ID: 21593693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intensive or conventional glucose control in critically ill patients: NICE-SUGAR (The Normoglycemia in Intensive Care Evaluation-Survival Using Glucose Algorithm Regulation Study)].
    Jacob S; Nitschmann S
    Internist (Berl); 2010 May; 51(5):670, 672-3. PubMed ID: 20352176
    [No Abstract]   [Full Text] [Related]  

  • 20. Are closed-loop systems for intensive insulin therapy ready for prime time in the ICU?
    Okabayashi T; Shima Y
    Curr Opin Clin Nutr Metab Care; 2014 Mar; 17(2):190-9. PubMed ID: 24378668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.